Raffles Medical Group is trading at 28 times the earnings, and more than 4 times the book value and I think the dividend also not so attractive (at least SH got better dividends for the valuation). Me thinks there are better options out there.
Yes, with ageing population comes increased healthcare cost but whether a company can take advantage is another question. There is always a right sector and a right company within the sector at the right price. The stars must align woh.
I will never buy at the current price. It is ridiculous!
Even assuming they can capitalise on the China market, it will take time for fruits to bear.